Bausch+Lomb Results Presentation Deck
IC-8® Apthera ™M IOL: Breakthrough Design Offering New Possibilities for Patients
+ The embedded FilterRing™ component delivers
high OQ ™M (optical quality) light to the retina and filters out
distorted low OQTM light entering the eye, providing a clear,
continuous range of vision
EEEE
Intermediate Far
Near
Low OQT Light
High OQ™ Light
BAUSCH + LOMB
Apthera™ IOL
94M People
affected globally
with cataracts¹
Near
Far
Intermediate
*Simulated Image
+ The distinctive design filters out unfocused peripheral light
that degrades image quality, allowing only central light rays to
focus on the retina
+ In clinical trials, the IC-8® IOL patients achieved equivalent
binocular distance and superior intermediate and near vision
compared to patients with bilateral monofocal 10Ls
Potential Market Opportunity
~13% CAGR
global premium cataract IOL
market projected to grow
between 2022 and 2027²
1. The World Health Organization: Blindness and Vision impairment.
2. Market Scope. 2022 IOL Market Report (April 2022). See Slide 1 for further information on forward-looking statements.
3. National Eye Institute. NEI charts a clearer future for cataract prevention and treatment. See Slide 1 for further information on forward-looking statements.
50M Expected
by 2050 in U.S.
to have cataracts,
doubling, from 24M
in 20213
22View entire presentation